C032642 | 4-aminophenylarsenoxide | 4-aminophenylarsenoxide binds to ANKS1A protein | 26598702 |
C032642 | 4-aminophenylarsenoxide | arsenic trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ANKS1A protein] | 26598702 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of ANKS1A mRNA | 22230336 |
D018501 | Antirheumatic Agents | Antirheumatic Agents results in increased expression of ANKS1A mRNA | 24449571 |
C006632 | arsenic trioxide | arsenic trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ANKS1A protein] | 26598702 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of ANKS1A mRNA | 20064835|2010694 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ANKS1A mRNA" | 19150397 |
C044887 | beta-methylcholine | beta-methylcholine affects the expression of ANKS1A mRNA | 21179406 |
C543008 | bis(4-hydroxyphenyl)sulfone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ANKS1A mRNA | 28628672 |
C006780 | bisphenol A | bisphenol A affects the expression of ANKS1A mRNA | 25181051 |
D003561 | Cytarabine | Cytarabine results in decreased expression of ANKS1A mRNA | 21198554 |
D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ANKS1A mRNA | 28628672 |
D002945 | Cisplatin | Cisplatin results in decreased expression of ANKS1A mRNA | 27594783 |
C000944 | dicrotophos | dicrotophos results in increased expression of ANKS1A mRNA | 28302478 |
C024629 | dimethyl phthalate | dimethyl phthalate affects the expression of ANKS1A mRNA | 26924002 |
D004237 | Diuron | Diuron results in decreased expression of ANKS1A mRNA | 21551480 |
D004791 | Enzyme Inhibitors | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ANKS1A protein | 23301498 |
C069837 | fullerene C60 | fullerene C60 results in increased expression of ANKS1A mRNA | 19167457 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of ANKS1A mRNA | 21179406 |
D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ANKS1A mRNA | 28628672 |
D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ANKS1A mRNA | 28628672 |
C028007 | nickel monoxide | nickel monoxide results in increased expression of ANKS1A mRNA | 19167457 |
C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in decreased expression of ANKS1A mRNA | 25729387 |
D011441 | Propylthiouracil | Propylthiouracil results in increased expression of ANKS1A mRNA | 24780913 |
D012999 | Soman | Soman results in increased expression of ANKS1A mRNA | 19281266 |
D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in decreased expression of ANKS1A mRNA | 25729387 |
D019772 | Topotecan | Topotecan results in decreased expression of ANKS1A mRNA | 25729387 |